![Jørgen Søberg Petersen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jørgen Søberg Petersen
Plus aucun poste en cours
Profil
Jørgen Søberg Petersen is currently Chairman & Chief Executive Officer at Rheumalogics ApS, Chairman at Acesion Pharma ApS, Director at Hemab ApS since 2022, Director at Tribune Therapeutics AB, and Director at Breye Therapeutics ApS.
Former positions include Chairman at Medical Prognosis Institute A, Partner at Novo Holdings A, Senior Vice President-Research at Merck Serono Ltd. from 2008 to 2013, and Member of the Supervisory Board at Therachon Holding GmbH.
Postes actifs de Jørgen Søberg Petersen
| Sociétés | Poste | Début |
|---|---|---|
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Directeur/Membre du Conseil | 05/01/2022 |
Acesion Pharma ApS
 Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation | Président | - |
Breye Therapeutics ApS
 Breye Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel oral therapies for retinal vascular diseases | Directeur/Membre du Conseil | - |
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Jørgen Søberg Petersen
| Sociétés | Poste | Fin |
|---|---|---|
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Directeur Technique/Scientifique/R&D | - |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Directeur/Membre du Conseil | - |
Medical Prognosis Institute A/S
 Medical Prognosis Institute A/S BiotechnologyHealth Technology Develops and researches prognostic products towards cancer treatment | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Develops and researches prognostic products towards cancer treatment | Health Technology |
Acesion Pharma ApS
Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation | Commercial Services |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Commercial Services |
Breye Therapeutics ApS
Breye Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel oral therapies for retinal vascular diseases | Health Technology |
